Odyssean »

Western New England Ban shares owned by Odyssean

Quarter-by-quarter ownership of Western New England Ban (WNEB) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Western New England Ban

Tip: Access up to 7 years of quarterly data

All positions including Western New England Ban held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Western New England Ban by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $177k 12k 14.30

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Western New England Ban

BlackRock
Dimensional Fund Advisors
Renaissance Technologies
Strategic Value Bank Partners
Vanguard Capital Management
Royce & Associates
Ameriprise Financial
Acadian Asset Management
Geode Capital Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Bridgeway Capital Management
Mangrove Partners
Federated Investors
O'shaughnessy Asset Management

View all funds holding Western New England Ban